2026 Oncology Conference: THMA Oncology Forum
May 6-8, 2026
Fort Lauderdale, FL
Today’s oncology market is shaped by rapid therapeutic innovation, pathway standardization, tighter access controls, health system consolidation, and increasing financial and operational pressure.
The THMA Oncology Forum connects pharma commercial leaders with senior oncology service line executives in a closed-door, peer-level setting designed for candid, strategic dialogue.
With a strict 1:1 health system-to-industry ratio, engage directly with the decision-makers who shape:
Clinical pathway inclusion, treatment sequencing, and real-world prescribing behavior
Formulary positioning, utilization management, and access execution workflows
Operational rollout and implementation across health system networks and sites of care
Gain early, provider-validated insight into what accelerates adoption, where uptake stalls, and how to align brand, field, and access strategies with real-world oncology realities.
Upcoming Event Dates and Locations
The Oncology Forum is hosted twice a year in thoughtfully selected locations across the country. Each event is timed to align with evolving industry priorities, providing a fresh opportunity to reconnect with peers, gain new insights, and advance your healthcare financial strategy.
Health System Forum Members
What Sets Oncology Forum Apart
The Right People, in the Right Room: All participants are carefully vetted and hand-selected to ensure meaningful contribution and strategic relevance. Attendees include senior Oncology Service Line Executives from leading health systems such as Mayo Clinic, Yale New Haven Health, Baptist MD Anderson Cancer Center, Baptist Health, and other nationally recognized organizations, alongside select industry leaders.
Purposeful Industry Participation: Industry partners are thoughtfully curated to support high-value dialogue and shared learning, creating an environment focused on insight generation rather than transactional networking.
Provider-Validated Intelligence: Gain unfiltered perspective on how oncology decisions are truly made, where implementation challenges emerge, and what drives sustainable adoption across health systems.
Relationships Built on Trust: The Forum is designed to foster long-term, credible relationships with oncology leaders through both structured engagement and informal connection, enabling continued collaboration beyond the event itself.
What Participants Are Saying
The Oncology Forum creates a purpose-built space for executive-level engagement. Every session, social setting, and touchpoint is curated to foster meaningful, candid dialogue between fellow Oncology Service Line Executives and select industry innovators, most commonly CEOs, Chief Growth Officers, and strategic product leaders.
Industry Forum Members
Topics include:
Integrating Oncology and Pharmacy Strategy: Oncology and pharmacy leaders from Banner Health shared how cross-functional partnerships are breaking down silos to improve patient access, enhance coordination, and strengthen financial sustainability. Members examined strategies for aligning clinical, operational, and financial stakeholders to deliver integrated cancer care.
Enhancing Access and Navigation in Cancer Care: Emory Healthcare leaders presented their Nurse Navigation Program and digital platform, Cancer Insights, which reduced medical record retrieval time from days to minutes. Discussions focused on redesigning patient access workflows to improve efficiency, experience, and care continuity across the oncology service line.
Advancing Precision Oncology Through Strategic Partnerships: Providence and Pfizer shared insights from their POWER initiative—Precision Oncology With Equitable Reach—illustrating how health systems and industry partners can co-create programs that expand access, leverage data for clinical decision-making, and embed equity into precision medicine strategies.
Navigating Ambulatory Infusion and Cell Therapy Models: Health systems explored build-versus-partner strategies for ambulatory infusion services and operational considerations for CAR-T cell therapy programs. Discussions highlighted infrastructure, logistics, and partnership models that enable innovative therapies to reach patients efficiently and sustainably.
The Oncology Forum Experience
At the Oncology Forum, you will discuss:
How pathway governance and cost pressures are reshaping prescribing decisions
Where evolving access requirements are creating friction or opportunity
What health systems need to efficiently adopt and sustain new therapies
These insights directly inform commercialization strategy, enabling faster traction, stronger pull-through, and more durable market impact.
Our Convening Experiences
Extending Value Beyond the Oncology Conference
Members gain access to a year-round ecosystem of insights and engagement through THMA’s Executive Insights Hub. This digital platform discusses trends and challenges unique to strategic planning, as well as trending CXO priorities, from large health systems across the country. Our other year-round resources include:
Quarterly Trend Reports: Digestible insights and follow-ups from live briefings and proprietary research.
Executive Edge: A Sunday evening digest with quick-read summaries of industry-impacting events.
Post-Forum Debriefs: Key takeaways and insights from our Forums - useful even for teammates who did not attend.
Healthcare Bootcamp: A library of short videos and modules to onboard new team members or sharpen your team’s healthcare knowledge.
About The Health Management Academy
Since 1998, The Health Management Academy has cultivated the premier membership-based community of healthcare’s most influential CXOs from top U.S. health systems, as well as decision makers from innovative industry companies.
We cultivate exceptional peer groups, providing original market insights, world-class leadership development programs, and novel member alliances to more than 2,000 health system senior executives and 200 industry organizations.
2,000+
Health System Executives
600+
Health System C-Suite Members
200+
Exec Industry Members
75%
Of U.S. Physicians
